Photo by Anthony Behar/Sipa USA)(Sipa via AP Images
Covid-19 roundup: FDA authorizes Pfizer-BioNTech booster for 12-to-15-year-olds; Early results suggest antivirals may hold up against Omicron
Children between the ages of 12 and 15 years old are now eligible for a third dose of the Pfizer-BioNTech vaccine after the FDA authorized …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
